Iovance Biotherapeutics (IOVA) Insider Trading & Ownership → See this before next week's Fed meeting (From Stansberry Research) (Ad) Free IOVA Stock Alerts $11.25 -0.46 (-3.93%) (As of 11:16 AM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Iovance Biotherapeutics (NASDAQ:IOVA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.40%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$28.84 MNumber OfInsiders Selling(Last 12 Months)0 Get IOVA Insider Trade Alerts Want to know when executives and insiders are buying or selling Iovance Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IOVA Insider Buying and Selling by Quarter Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItSee this before next week's Fed Meeting Thousands of investing ideas come across his desk every year… But Doc Eifrig just revealed THIS ONE "will go down as one of the smartest and most lucrative financial moves of the decade." (Last time we shared this, it led to a 995% gain.)Get the free details now. Iovance Biotherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/20/2024Merrill A McpeakDirectorBuy250,000$9.15$2,287,500.00 9/18/2023Merrill A McpeakDirectorBuy10,000$5.56$55,600.00 9/15/2023Wayne P RothbaumDirectorBuy5,000,000$5.30$26,500,000.00 (Data available from 1/1/2013 forward) IOVA Insider Trading Activity - Frequently Asked Questions Who is on Iovance Biotherapeutics's Insider Roster? The list of insiders at Iovance Biotherapeutics includes Frederick G Vogt, Iain D Dukes, Merrill A Mcpeak, and Wayne P Rothbaum. Learn more on insiders at IOVA. What percentage of Iovance Biotherapeutics stock is owned by insiders? 10.40% of Iovance Biotherapeutics stock is owned by insiders. Learn more on IOVA's insider holdings. Which Iovance Biotherapeutics insiders have been buying company stock? The following insiders have purchased IOVA shares in the last 24 months: Frederick G Vogt ($12,420.00), Iain D Dukes ($61,000.00), Merrill A Mcpeak ($2,534,800.00), and Wayne P Rothbaum ($91,500,000.00). How much insider buying is happening at Iovance Biotherapeutics? Insiders have purchased a total of 15,302,000 IOVA shares in the last 24 months for a total of $94,108,220.00 bought. More Insider Trading Tools from MarketBeat Related Companies: ImmunityBio Insider Buying SpringWorks Therapeutics Insider Buying Apogee Therapeutics Insider Buying Arcellx Insider Buying Immunocore Insider Buying CG Oncology Insider Buying Denali Therapeutics Insider Buying Vericel Insider Buying Immunovant Insider Buying Beam Therapeutics Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:IOVA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap Profits“The Biggest Bubble of All Time” – Here’s What to Do.Chaikin AnalyticsYour Money is Not SafeAmerican Alternativetop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iovance Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
